PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Promethazine Hydrochloride And Codeine Phosphate, and when can generic versions of Promethazine Hydrochloride And Codeine Phosphate launch?
Promethazine Hydrochloride And Codeine Phosphate is a drug marketed by Actavis Mid Atlantic, Amneal Pharms, Hikma, Nostrum Labs Inc, Pharm Assoc, Quagen, Tris Pharma Inc, and Wockhardt Bio Ag. and is included in eight NDAs.
The generic ingredient in PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE is codeine phosphate; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the codeine phosphate; promethazine hydrochloride profile page.
Summary for PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
US Patents: | 0 |
Applicants: | 8 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 6 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE at DailyMed |
Pharmacology for PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
Drug Class | Opioid Agonist Phenothiazine |
Mechanism of Action | Full Opioid Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
US Patents and Regulatory Information for PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Mid Atlantic | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | codeine phosphate; promethazine hydrochloride | SYRUP;ORAL | 088763-001 | Oct 31, 1984 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Tris Pharma Inc | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | codeine phosphate; promethazine hydrochloride | SYRUP;ORAL | 200386-001 | Jun 29, 2012 | AA | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Nostrum Labs Inc | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | codeine phosphate; promethazine hydrochloride | SYRUP;ORAL | 090180-001 | Mar 17, 2010 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Wockhardt Bio Ag | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | codeine phosphate; promethazine hydrochloride | SYRUP;ORAL | 088875-001 | Dec 17, 1984 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Amneal Pharms | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | codeine phosphate; promethazine hydrochloride | SYRUP;ORAL | 200894-001 | Apr 24, 2013 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |